Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange decided to delist MERIDIAN shares

2/23/23 MERF

Moscow Exchange decided to delist the shares of INVEST-DEVELOPMENT

2/23/23 IDVP

Amazon bought 1Life Healthcare

2/22/23 ONEM

The eBay announced a quarterly dividend

2/22/23 EBAY

The NVIDIA announced a quarterly dividend

2/22/23 NVDA

Whoosh plans to pay a dividend in the fall of 2023

2/22/23 WUSH

The Intel announced a quarterly dividend

2/22/23 INTC

VK acquires 18.36% in Sape, an ecosystem for website promotion and monetization

2/22/23 VKCO

Whoosh in the new season will begin work in 10 locations in Russia and the CIS

2/22/23 WUSH

Whoosh bought 45,000 scooters

2/22/23 WUSH